www.fdanews.com/articles/71302-jazz-pharmaceuticals-to-acquire-orphan-medical
Jazz Pharmaceuticals to Acquire Orphan Medical
April 19, 2005
Jazz Pharmaceuticals, Inc. and Orphan Medical, Inc. announced that they have entered into an agreement and plan of merger pursuant to which Jazz Pharmaceuticals, through a wholly owned subsidiary, will acquire Orphan Medical. Under the agreement, which was unanimously approved by Orphan Medical's board of directors, Orphan Medical common stockholders will receive $10.75 per share in cash upon the close of the transaction. Following the merger, Orphan Medical will become a wholly owned subsidiary of Jazz Pharmaceuticals, a privately held company.